ERBB2 and breast carcinoma: To assess whether scPharm can accurately identify a sensitive subpopulation from single‐cell data, we analysed scRNA‐seq data from six HER2‐positive human breast cancer tissue samples, namely, MH0176, MH0031, MH0069, PM0337, AH0308 and MH0161.